CORC

浏览/检索结果: 共19条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yu, Pengfei;  Du, Yian;  Xu, Zhiyuan;  Yang, Litao;  Ying, Jieer
收藏  |  浏览/下载:9/0  |  提交时间:2022/12/23
Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Xu, Xiaoqing;  Li, Jingjing;  Gao, Yiding;  Lv, Wangxia;  Wei, Qing
收藏  |  浏览/下载:21/0  |  提交时间:2022/05/16
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9
作者:  Chen, Xiaofeng;  Wang, Deqiang;  Liu, Jing;  Qiu, Jingrong;  Zhou, Jun
收藏  |  浏览/下载:32/0  |  提交时间:2022/01/10
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9
作者:  Ying, Jieer;  Yang, Lin;  Yin, Jiani C.;  Xia, Guojie;  Xing, Minyan
收藏  |  浏览/下载:26/0  |  提交时间:2021/11/15
Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Guo, Weijian;  Zhu, Xiaodong;  Huang, Mingzhu;  Wang, Yusheng;  Chen, Zhiyu
收藏  |  浏览/下载:26/0  |  提交时间:2022/01/10
System inflammation markers of resectable colorectal cancer patients with different mismatch repair gene status. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li Jingjing;  Zhang, Yiwen;  Qi, Xu;  Wei, Qing;  Ying, Jieer
收藏  |  浏览/下载:6/0  |  提交时间:2022/01/10
A phase 2 study of tislelizumab monotherapy in patients with previously treated, locally advanced unresectable ormetastatic microsatellite instability-high/mismatch repair deficient solid tumors. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jian;  Xu, Ye;  Zang, Aimin;  Gao, Yunong;  Gao, Quanli
收藏  |  浏览/下载:22/0  |  提交时间:2022/01/10
A cross-sectional study on effectiveness of antiemetic regimens for chemotherapy-induced nausea and vomiting: A single-center retrospect study of 1,000 patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Cong, Luo;  Shang, Mingge;  Chen, Lei;  Qi, Xu;  Li Jingjing
收藏  |  浏览/下载:9/0  |  提交时间:2022/01/10
The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Xu, Jianming;  Zhang, Yun;  Wu, Jun;  Xu, Nong;  Ying, Jieer
收藏  |  浏览/下载:20/0  |  提交时间:2022/01/10
Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Yuan, Ying;  Fu, Xianhua;  Ying, Jieer;  Yang, Liu;  Fang, Weijia
收藏  |  浏览/下载:7/0  |  提交时间:2022/01/10


©版权所有 ©2017 CSpace - Powered by CSpace